Retraction
Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study
Paper Information
Record ID:
48330
Author(s):
Journal:
Publication Date:
August 23, 2022
Retraction Date:
August 02, 2023
(2.3 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institution:
Department of Integrated Chinese and Western Medicine Oncology, Hangzhou Cancer Hospital, Hangzhou 310002, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations2
Post-Retraction(50.0%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
478
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Combinatorial treatment with traditional medicinal preparations and VEGFR-tyrosine kinase inhibitors for middle-advanced primary liver cancer: A systematic review and meta-analysis
Huibo Yu, Jiaqi Hu, Bao-Jin Han et al. (9 authors)
PLoS ONE
Open Access
Published: Nov 2024
478 days after retraction
Diagnostic significance of alanine aminotransferase isoenzymes in alcoholic and non-alcoholic fatty liver cancers
Dandan Zhou, Zuowei Yuan, Xiaoqin Shu et al. (12 authors)
Bioscience Reports
Open Access
Published: Oct 2023
2 citations
2 citations
85 days after retraction
Retracted: Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study
Computational Intelligence and Neuroscience
Computational Intelligence and Neuroscience
Open Access
Published: Jan 2023
213 days before retraction
Quick Stats
Total Citations:
5
Years Since Retraction:
2.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025